Home › Shire strikes $6.5 bn deal for US biotech firm Dyax Corp
 

Keywords :   


Shire strikes $6.5 bn deal for US biotech firm Dyax Corp

2015-11-04 02:33:35| Biotech - Topix.net

Dublin-based drug maker Shire said it has struck an all-cash $6.5 billion deal for US biotech Dyax Corp., even as it chases a $30 billion deal for rare-disease rival Baxalta Inc. Dyax shareholders will receive an additional $4 a share if certain performance targets are met, which would increase the overall value of the deal by $646 million. Based in Burlington, Massachusetts, Dyax has specialized in the development of treatments for HAE, a rare genetic disease that can be life-threatening.

Tags: deal firm corp strikes

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
28.09Post-Tropical Cyclone Helene Public Advisory Number 20
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 10
28.09Hurricane Isaac Wind Speed Probabilities Number 10
28.09Hurricane Isaac Public Advisory Number 10
28.09Summary for Hurricane Isaac (AT5/AL102024)
28.09Hurricane Isaac Forecast Advisory Number 10
More »